Aug 2018
1 dated step on the record this month, newest first.
- Onpattro
The FDA approved Onpattro, a first-of-its-kind RNA-based medicine, for nerve damage caused by hereditary ATTR amyloidosis in adults.
Approved or on sale
1 dated step on the record this month, newest first.
The FDA approved Onpattro, a first-of-its-kind RNA-based medicine, for nerve damage caused by hereditary ATTR amyloidosis in adults.